A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis

Mise à jour : Il y a 5 ans
Référence : NCT01166282

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy and safety of adalimumab given subcutaneously every other week (eow) as compared to placebo in pediatric subjects with Enthesitis Related Arthritis (ERA).


Critère d'inclusion

  • Enthesitis Related Arthritis (ERA)


Liens